SCHEMBL16019774

SCHEMBL16019774

Cc1nn(C)c(C(=O)Nc2ccc(-c3cc(C(F)(F)F)nn3C)c(F)c2)c1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.50
LMNA P02545 3/20 0.45
MAPT P10636 3/20 0.44
POLB P06746 2/20 0.44
ALPL P05186 1/20 0.44
GAA P10253 1/20 0.44
HTT P42858 1/20 0.44
RAB9A P51151 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
NPC1 O15118 2/20 0.42
STIM1 Q13586 2/20 0.41
ORAI1 Q96D31 2/20 0.41
KDM4E B2RXH2 3/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
HPGD P15428 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16019779 0.90 ALDH1A1 (0.45) ALDH1A1LMNAMAPTPOLBHTT
SCHEMBL16017243 0.89 ALDH1A1 (0.42) ALDH1A1LMNAMAPTPOLBHTT
SCHEMBL16017250 0.87 RAF1 (0.42) ALDH1A1MAPTPOLBRAB9ASMN1; SMN2
SCHEMBL16017176 0.84 STIM1 (0.41) ALDH1A1MAPTPOLBRAB9ASMN1; SMN2
SCHEMBL29420773 0.84 MAPT (0.52) ALDH1A1MAPTHTTRAB9ASMN1; SMN2
SCHEMBL16017420 0.84 MAPT (0.52) ALDH1A1MAPTHTTRAB9ASMN1; SMN2
SCHEMBL16017227 0.82 KDM4E (0.44) ALDH1A1MAPTPOLBRAB9ASMN1; SMN2
SCHEMBL16017189 0.82 STIM1 (0.51) ALDH1A1LMNAPOLBHTTRAB9A
SCHEMBL16017419 0.81 ALDH1A1 (0.50) ALDH1A1POLBRAB9ASMN1; SMN2NPC1
SCHEMBL16017183 0.81 CRACR2A (0.55) ALDH1A1MAPTRAB9ASMN1; SMN2STIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. 2014-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 ALDH1A1 4409/4885LMNA 1306/4885MAPT 1478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.